Dark Genome Target Discovery and Development Summit Hilton Boston Back Bay, Boston

Welcome to the Inaugural Dark Genome Target Discovery and Development Summit

The Dawn of the Dark Genome Has Arrived…

Significant technological advances in computational biology, next-gen sequencing, -omics platforms and AI have unlocked the transformative potential of drug discovery in the dark genome, resulting in investment and partnerships totalling over $1.5 billion in the past 6 months alone.

Designed to bring together the growing community of pioneers, the inaugural Dark Genome Target Discovery and Development Summit is the first industry-focused forum to decipher the mysteries of non-coding DNA and RNA to reveal its role in disease, while uncovering and validating novel targets across oncology, neuroscience, aging, heart disease and beyond!

Featuring a star-studded speaker line-up of ROME Therapeutics, HAYA Therapeutics, Mnemo Therapeutics, Eli Lilly and Company, HERVolution, CAMP4 Therapeutics, Nucleome, Immatics, and more, join forces with industry experts across discovery, genomics, proteomics, data science, AI, bioinformatics and computational biology to enlighten a new paradigm for drug discovery.